Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: steatorrhea and abdominal pain. major surgical or invasive procedure: pylorus-perserving whipple and open cholecystectomy history of present illness: mrs. if a delightful 47-year-old woman who has suffered from abdominal discomfort and apparent steatorrhea and has been imaged by endoscopic procedures and found to have a pancreatic ductal abnormality and cellular atypia on brush cytology. while no definitive mass was identified on ct angiography, there is no evidence of metastatic disease and nothing to suggest unresectable carcinoma of the pancreatic head. nevertheless, on the basis of a suspected but unproven malignancy, definitive resection was recommended to the patient, especially in light of the cellular atypia. more worrisome is that the pancreatic duct itself was dilated out proximal to this body and tail of the pancreas. she had no antecedent history of biliary obstruction. past medical history: seasonal allergies vaginal hysterectomy (partial ovary remains), bladder band social history: patient lives on . she moved there from to raise her children. family history: no family history of pancreatitis. physical exam: vs: t: 97.7, bp: 124/50, hr: 99, rr: 20, sao2: 94% ra gen: a+ox3 in nad. heent: sclerae anicteric. o-p moist, intact. neck: supple. no lymphadenopathy. lungs: cta(b). adb: incision with steri-strips c/d/i. abd soft/nt/nd. extrem: no c/c/e. skin: as above, otherwise well-perfused, intact. pertinent results: 03:58pm glucose-144* urea n-12 creat-0.5 sodium-140 potassium-4.9 chloride-108 total co2-25 anion gap-12 03:58pm wbc-24.0*# rbc-3.38* hgb-11.4* hct-31.8* mcv-94 mch-33.6* mchc-35.7* rdw-13.2 03:58pm plt count-439 03:58pm pt-13.9* inr(pt)-1.2* 02:42pm glucose-113* lactate-2.7* na+-141 k+-5.0 cl--110 02:42pm freeca-1.08* 01:45pm glucose-126* lactate-1.5 na+-139 k+-3.4* cl--107 01:45pm hgb-11.3* calchct-34 10:46am glucose-123* lactate-1.6 na+-138 k+-4.6 cl--99* 10:46am hgb-12.9 calchct-39 . micro sputumcx: contaminated bcx: pending urinecx: pending viral screen: no growth bal: no growth cmv: negative sputum: dirty blood: pending pathology = chronic pancreatitis . torso ct w/ contrast: 1. bilateral pleural effusions and compressive atelectasis, with a possible concomitant focus of lll infectious consolidation. overall significant improvement in pulmonary parenchymal aeration with mild residual ground-glass reticular opacities. 2. adrenal indistinctness and fat stranding, raising the possibility of adrenalitis/hemorrhage. clinical correlation is recommended. 3. mediastinal and hilar adenopathy,slightly improved. could reflect reactive changes. document resolution after treatment. 4. focal area of low attenuation in the left hepatic lobe (2:62) measuring 1.1 x 1.6 cm with peripheral rim of enhancement and a small anterior fluid collection. this could represent retractor/clamp-related injury during the surgery or a small focus of infection. correlation with ultrasound is recommended. 5. small non-occlusive filling defect in the right internal jugular vein. brief hospital course: the patient was admitted to the general surgical service for evaluation and treatment. underwent pylorus-preserving whipple and open cholecystectomy without complication. after a brief, uneventful stay in the pacu, the patient arrived on the floor npo, on iv fluids, with a foley catheter, ng tube and jp in place. she was on a dilaudid pca for pain control with adequate pain control. the patient was hemodynamically stable. : remained stable on ivf, npo. pain well controlled on dilaudid pca. on pathway w/o events. : experienced diffuse wheezes, bothersome cough. o2 requirement 3l. blood and sputum cultures sent. started on xopenex and atrovent nebulizer treatments. hemodynamically stable at that time. : worsened from respiratory standpoint; cxr revealed developing bilateral infiltrates consistent with pneumonia. chest ct confirmed finding; did not reveal pe. abg was 7.46/42/98/31. she was placed on a nrb with improved sao2 in 90s. iv vancomycin started. due to further worsening of tachypnea and hypoxia, patient was transfered to the sicu. once arrived on icu, iv levaquin was also started, patient was presumptively placed on heparin drip as a precaution against pe, lovenox restarted. intensive respiratory therapy. gentle diuresis. continued on a dilaudid pca for pain control with good effect. a-line placed with improvement of pao2. cough improved with cough supressants. blood cultures sent. : started on iv zosyn. continued intensive respiratory toilet and pt. -pharygeal and expectorate sputum cultures sent. intubated. underwent bronchoscopy with bal of (r)lower lobe and (l) upper lobe. : extubated in morning, maintaining saturation. vancomycin dose increased. started on sips, then clears with good tolerability. : tolerating face mask, tolerating regular diet, iv kvo. : decreased o2 requirement, cvl discontinued. changed to po medications. transfered back to floor on po levaquin as only antibiotic. : experienced severe lower back spasms most likely from prolonged time in bed; treated successfully with iv dilaudid and valium, subsequently converted to po medications. increased activity out of bed also helped to resolve issue. : continued increasing activity level with improved tolerance and decreasing o2 demand, until patient able to ambulate the floor without supplemental oxygen. continued on aggressive nebulizer treatments and chest physical therapy. tolerated diet. muscle spasms subsided and pain well controlled. repeat torso ct and cxr demonstrated improvement of pleural effusions as patient continued on po levaquin. also, no leaks or fluid collections evident on abdominal/pelvic portion of ct study. : patient demonstrated ability to ambulate floor and up/down stairs with stable sao2 and pulse, without the need of supplemental oxygen. pain remained well controlled. tolerating regular diet. no further signifiant events. at the time of discharge, the patient was doing well, afebrile with stable viral signs. the patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. respiratory status was stable on inhalers. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: hydrochlorothiazide 25, lovenox, percocet discharge medications: 1. hydromorphone 2 mg tablet sig: 1-2 tablets po q3h (every 3 hours) as needed. disp:*60 tablet(s)* refills:*0* 2. nicotine 14 mg/24 hr patch 24 hr sig: one (1) patch 24 hr transdermal daily (daily). disp:*60 patch 24 hr(s)* refills:*2* 3. acetaminophen 325 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed. 4. diazepam 2 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed. disp:*60 tablet(s)* refills:*0* 5. colace 100 mg capsule sig: one (1) capsule po twice a day. disp:*60 capsule(s)* refills:*2* 6. senna 8.6 mg capsule sig: one (1) capsule po twice a day. disp:*60 capsule(s)* refills:*2* 7. omeprazole 40 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day. disp:*30 capsule, delayed release(e.c.)(s)* refills:*2* 8. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation four times a day as needed for cough. disp:*1 mdi* refills:*2* 9. dextromethorphan-guaifenesin 10-100 mg/5 ml liquid sig: mls po q4h (every 4 hours) as needed. 10. fluticasone-salmeterol 100-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). disp:*60 disk with device(s)* refills:*2* 11. lovenox 80 mg/0.8 ml syringe sig: seventy (70) mg subcutaneous twice a day: take 0.7 mg of the 0.8 mg syringe to deliver 70 mg per dose. discharge disposition: home discharge diagnosis: chronic cholecystitis, severe chronic pancreatitis, moderate pancreatic duct dysplasia (panin ii) and focal squamous metaplasia of common bile and pancreatic ducts discharge condition: good discharge instructions: please call your doctor or return to the er for any of the following: * you experience new chest pain, pressure, squeezing or tightness. * new or worsening cough or wheezing. * if you are vomiting and cannot keep in fluids or your medications. * you are getting dehydrated due to continued vomiting, diarrhea or other reasons. signs of dehydration include dry mouth, rapid heartbeat or feeling dizzy or faint when standing. * you see blood or dark/black material when you vomit or have a bowel movement. * your pain is not improving within 8-12 hours or not gone within 24 hours. call or return immediately if your pain is getting worse or is changing location or moving to your chest or back. *avoid lifting objects > 5lbs until your follow-up appointment with the surgeon. *avoid driving or operating heavy machinery while taking pain medications. * you have shaking chills, or a fever greater than 101.5 (f) degrees or 38(c) degrees. * any serious change in your symptoms, or any new symptoms that concern you. * please resume all regular home medications and take any new meds as ordered. * continue to ambulate several times per day. incision care: -your steri-strips will fall off on their own. -you may shower, and wash surgical incisions. -avoid swimming and baths until your follow-up appointment. -please call the doctor if you have increased pain, swelling, redness, or drainage from the incision sites. followup instructions: follow up with dr. on at 10:45 in 3. please call to confirm or change your appointment (if needed). procedure: radical pancreaticoduodenectomy other intubation of respiratory tract cholecystectomy closed [endoscopic] biopsy of bronchus diagnoses: pneumonia, organism unspecified hypocalcemia anemia, unspecified unspecified essential hypertension hypopotassemia disorders of phosphorus metabolism other emphysema personal history of venous thrombosis and embolism other postprocedural status other specified intestinal malabsorption chronic pancreatitis other symptoms referable to back other abnormal glucose chronic cholecystitis 

Answer: The patient is high likely exposed to